Published :
Tables : 48
Figures : 45
Category : Healthcare
No. of Pages : 220
Report Code : HC-1150
Respiratory Care Devices Market Overview: Respiratory care devices are used to diagnose, monitor, and treat respiratory disorders as COPD, asthma, tuberculosis, and pneumonia. Patients suffering from acute and chronic respiratory illnesses benefit from respiratory care devices. Patients with cardiopulmonary devices are treated, assessed, diagnosed, and cared for using respiratory care devices. Patients with cardiopulmonary devices are treated, assessed, diagnosed, and cared for using respiratory care devices. Lung disorders such as chronic bronchitis, TB, acute and chronic pulmonary diseases, asthma, and others are treated with respiratory care devices. The function of the lungs begins to deteriorate as people age, and the respiratory system undergoes a variety of physiological, functional, and immunological changes as a result. The rise in chronic pulmonary disorders, asthma, and other respiratory ailments is driving the market for respiratory care equipment. These gadgets, which have evolved from stationary to portable, can be employed in hospitals and in-home care settings. The respiratory care devices market is expected to increase due to factors such as the rising prevalence of respiratory disorders, the growing geriatric population, urbanisation and its negative consequences, and changes in the environment and lifestyle. The rising need for point-of-care diagnostic equipment in developing countries is expected to open up new prospects for respiratory care devices manufacturers. The rise of respiratory care devices market is hampered by a lack of awareness about respiratory disorders, severe competition, and the costs connected with the device and respiratory surgery. Patients with impaired respiratory functions are supplied with breathing gas mechanically through respiratory devices. With assisted respiration, an overpressure supports the natural breathing effort. In modern respiratory devices, the inhalations and exhalations are automatically adjusted. As emergency respiratory devices, long-term respiratory devices, and mobile home respiratory devices, respiratory devices can be adapted for a number of needs. When controlling (triggering) high-quality respiratory devices, early detection of the patient's inhalation phase is an important element. This is the only way the device can minimize the patient's respiratory effort. Today, the spontaneous breathing effort of the patient and the whole respiratory activity are usually monitored by a highly sensitive thermal mass flow sensor or another highly dynamic differential pressure sensor. FutureWise Market Research has instantiated a report that provides an intricate analysis of Respiratory Care Devices Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share, and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market. According to the research study conducted by FutureWise research analysts, the Respiratory Care Devices Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical. Impact of COVID-19 on Respiratory Care Devices Market: There has been a surge in the demand of respiratory devices like the ventilators which shall propel the market growth. Furthermore, the governments are swiftly taking steps in making important alliances with ventilator manufacturers to tackle the threat of novel coronavirus. In the U.K., the administration has requested automobile manufacturers such as Honda, Rolls Royce and Ford to develop respiratory equipment on the lineup that produces HVAC systems for cars. The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) are making an agreement with the manufacturers to make sure that these manufacturers follow the regulations and norms required to manufacture a respiratory device. Major players included in the Respiratory Care Devices Market: • Medtronic • Philips Healthcare • ResMed Inc • Fisher & Paykel Healthcare Co. Ltd • Masimo Corp • Getinge AB • Dragerwerk AG • Air Liquide • Vyaire Medical • Invacare Corp • Chart Industries Inc Respiratory Care Devices Market Segmentation: By Product • Therapeutic Devices o PAP Devices o Ventilators o Nebulizers o Humidifiers o Oxygen Concentrators o Inhalers o Reusable Resuscitators o Nitric Oxide Delivery Units o Oxygen Hoods • Monitoring Devices o Pulse Oximeters o Capnographs o Gas Analyzers • Diagnostic Devices o Spirometers o Polysomnography Devices o Peak Flow Meters o Other Diagnostic Devices • Consumables and Accessories o Masks o Reusable Masks o Nasal Masks o Full-face Masks o Nasal pillow masks o Oral Masks o Disposable Mask o Disposable Resuscitators o Tracheostomy Tubes o Nasal Cannulas o Other Consumables and Accessories By Indication • Chronic Obstructive Pulmonary Disease (COPD) • Asthma • Sleep Apnea • Infectious Disease • Other diseases By End-User • Hospitals • Home Care Settings • Ambulatory Care Centers By Region • North America • Latin America • Europe • Asia Pacific • Middle East & Africa Respiratory Care Devices Market Video Sample: Competitive Landscape: Product launches, mergers, and acquisitions had a positive influence on the market. Fisher Paykel in 2019 launched a new product F&P Optiflow 3S, a Nasal Cannula in a bid to bolster its position in the market Philips launched its first sleep and respiratory education center in Singapore in 2018 ResMed in 2019, acquired HB Healthcare Safety. The move bolstered the supply of respiratory care devices and home-based medical equipment for sleep FutureWise Key Takeaways: Monitoring devices are expected to propel the market during the forecast period. The availability of pulse oximetry in the form of innovative products like bluetooth enabled and fingertip pulse oximeters is expected to accelerate the market growt Technological advancements in the form of E-Nose and enhanced portable respiratory devices will play a major role in strengthening the market during the forecast period Objectives of the Study: To provide with an exhaustive analysis on the global respiratory care devices market by product, by indication, by end-user and by region To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) To evaluate and forecast micro-markets and the overall market To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America and Middle East & Africa To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions Profiling of companies to evaluate their market shares, strategies, financial and core competencies Flexible Delivery Model: We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement The customization Mobility Care offered are free of charge with purchase of any license of the report You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Respiratory care devices are used to diagnose, monitor, and treat respiratory disorders as COPD, asthma, tuberculosis, and pneumonia. Patients suffering from acute and chronic respiratory illnesses benefit from respiratory care devices. Patients with cardiopulmonary devices are treated, assessed, diagnosed, and cared for using respiratory care devices. Patients with cardiopulmonary devices are treated, assessed, diagnosed, and cared for using respiratory care devices. Lung disorders such as chronic bronchitis, TB, acute and chronic pulmonary diseases, asthma, and others are treated with respiratory care devices. The function of the lungs begins to deteriorate as people age, and the respiratory system undergoes a variety of physiological, functional, and immunological changes as a result. The rise in chronic pulmonary disorders, asthma, and other respiratory ailments is driving the market for respiratory care equipment. These gadgets, which have evolved from stationary to portable, can be employed in hospitals and in-home care settings. The respiratory care devices market is expected to increase due to factors such as the rising prevalence of respiratory disorders, the growing geriatric population, urbanisation and its negative consequences, and changes in the environment and lifestyle. The rising need for point-of-care diagnostic equipment in developing countries is expected to open up new prospects for respiratory care devices manufacturers. The rise of respiratory care devices market is hampered by a lack of awareness about respiratory disorders, severe competition, and the costs connected with the device and respiratory surgery.
Patients with impaired respiratory functions are supplied with breathing gas mechanically through respiratory devices. With assisted respiration, an overpressure supports the natural breathing effort. In modern respiratory devices, the inhalations and exhalations are automatically adjusted. As emergency respiratory devices, long-term respiratory devices, and mobile home respiratory devices, respiratory devices can be adapted for a number of needs. When controlling (triggering) high-quality respiratory devices, early detection of the patient's inhalation phase is an important element. This is the only way the device can minimize the patient's respiratory effort. Today, the spontaneous breathing effort of the patient and the whole respiratory activity are usually monitored by a highly sensitive thermal mass flow sensor or another highly dynamic differential pressure sensor.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Respiratory Care Devices Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share, and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Respiratory Care Devices Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.
Impact of COVID-19 on Respiratory Care Devices Market: There has been a surge in the demand of respiratory devices like the ventilators which shall propel the market growth. Furthermore, the governments are swiftly taking steps in making important alliances with ventilator manufacturers to tackle the threat of novel coronavirus. In the U.K., the administration has requested automobile manufacturers such as Honda, Rolls Royce and Ford to develop respiratory equipment on the lineup that produces HVAC systems for cars. The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) are making an agreement with the manufacturers to make sure that these manufacturers follow the regulations and norms required to manufacture a respiratory device.
Major players included in the Respiratory Care Devices Market: • Medtronic • Philips Healthcare • ResMed Inc • Fisher & Paykel Healthcare Co. Ltd • Masimo Corp • Getinge AB • Dragerwerk AG • Air Liquide • Vyaire Medical • Invacare Corp • Chart Industries Inc
Respiratory Care Devices Market Segmentation:
By Product • Therapeutic Devices o PAP Devices o Ventilators o Nebulizers o Humidifiers o Oxygen Concentrators o Inhalers o Reusable Resuscitators o Nitric Oxide Delivery Units o Oxygen Hoods • Monitoring Devices o Pulse Oximeters o Capnographs o Gas Analyzers • Diagnostic Devices o Spirometers o Polysomnography Devices o Peak Flow Meters o Other Diagnostic Devices • Consumables and Accessories o Masks o Reusable Masks o Nasal Masks o Full-face Masks o Nasal pillow masks o Oral Masks o Disposable Mask o Disposable Resuscitators o Tracheostomy Tubes o Nasal Cannulas o Other Consumables and Accessories
By Indication • Chronic Obstructive Pulmonary Disease (COPD) • Asthma • Sleep Apnea • Infectious Disease • Other diseases
By End-User • Hospitals • Home Care Settings • Ambulatory Care Centers
By Region • North America • Latin America • Europe • Asia Pacific • Middle East & Africa
Respiratory Care Devices Market Video Sample:
Competitive Landscape:
FutureWise Key Takeaways:
Objectives of the Study:
Flexible Delivery Model:
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Respiratory Care Devices Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Respiratory Care Devices Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Respiratory Care Devices Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Respiratory Care Devices Market, By Product Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Therapeutic Devices 7.1.1. PAP Devices 7.1.2. Ventilators 7.1.3. Nebulizers 7.1.4. Humidifiers 7.1.5. Oxygen Concentrators 7.1.6. Inhalers 7.1.7. Reusable Resuscitators 7.1.8. Nitric Oxide Delivery Units 7.1.9. Oxygen Hoods 7.2. Monitoring Devices 7.2.1. Pulse Oximeters 7.2.2. Capnographs 7.2.3. Gas Analyzers 7.3. Diagnostic Devices 7.3.1. Spirometers 7.3.2. Polysomnography Devices 7.3.3. Peak Flow Meters 7.3.4. Other Diagnostic Devices 7.4. Consumables and Accessories 7.4.1. Masks 7.4.2. Reusable Masks 7.4.3. Nasal Masks 7.4.5. Full-face Masks 7.4.6. Nasal pillow masks 7.4.7. Oral Masks 7.4.8. Disposable Mask 7.4.9. Disposable Resuscitators 7.4.10. Tracheostomy Tubes 7.4.11. Nasal Cannulas 7.4.12. Other Consumables and Accessories 8. Respiratory Care Devices Market, By Indication Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Chronic Obstructive Pulmonary Disease (COPD) 8.2. Asthma 8.3. Sleep Apnea 8.4. Infectious Disease 8.5. Other diseases 9. Respiratory Care Devices Market, By End-User Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Hospitals 9.2. Home Care Settings 9.3. Ambulatory Care Centers 10. North America Respiratory Care Devices Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 10.2.1. U.S.A 10.2.2. Canada 10.2.3. Mexico 10.3. Market Size (USD Million) Forecast for North America 2022-2028 11. Latin America Respiratory Care Devices Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. Brazil 11.2.2. Venezuela 11.2.3. Argentina 11.2.4. Rest of Latin America 11.3. Market Size (USD Million) Forecast for Latin America 2022-2028 12. Europe Respiratory Care Devices Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Germany 12.2.2. U.K 12.2.3. France 12.2.4. Italy 12.2.5. Spain 12.2.6. Russia 12.2.7. Poland 12.2.8. Rest of Europe 12.3. Market Size (USD Million) Forecast for Europe 2022-2028 13. Asia Pacific Respiratory Care Devices Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Japan 13.2.2. China 13.2.3. India 13.2.4. Australia and New Zealand 13.2.5. ASEAN 13.2.6. Rest of Asia Pacific 13.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028 14. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. GCC 14.2.2. Israel 14.2.3. South Africa 14.2.4. Rest of MEA 14.3. Market Size (USD Million) Forecast for MEA 2022-2028 15. Market Share Analysis and Competitive Landscape 15.1. Global Landscape - Key Players, Revenue and Presence 15.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 15.3. Global Emerging Companies 15.4. North America - Market Share Analysis and Key Regional Players 15.5. Europe - Market Share Analysis and Key Regional Players 15.6. Asia Pacific - Market Share Analysis and Key Regional Players 15.7. Global Key Player - Growth Matrix 16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 16.1. Medtronic 16.1.1. Company Overview 16.1.2. Product Portfolio 16.1.3. SWOT Analysis 16.1.4. Financial Overview 16.1.5. Strategic Overview 16.2. Philips Healthcare 16.2.1. Company Overview 16.2.2. Product Portfolio 16.2.3. SWOT Analysis 16.2.4. Financial Overview 16.2.5. Strategic Overview 16.3. ResMed Inc. 16.3.1. Company Overview 16.3.2. Product Portfolio 16.3.3. SWOT Analysis 16.3.4. Financial Overview 16.3.5. Strategic Overview 16.4. Fisher & Paykel Healthcare Co. Ltd. 16.4.1. Company Overview 16.4.2. Product Portfolio 16.4.3. SWOT Analysis 16.4.4. Financial Overview 16.4.5. Strategic Overview 16.5. Masimo Corp. 16.5.1. Company Overview 16.5.2. Product Portfolio 16.5.3. SWOT Analysis 16.5.4. Financial Overview 16.5.5. Strategic Overview 16.6. Getinge AB 16.6.1. Company Overview 16.6.2. Product Portfolio 16.6.3. SWOT Analysis 16.6.4. Financial Overview 16.6.5. Strategic Overview 16.7. Dragerwerk AG 16.7.1. Company Overview 16.7.2. Product Portfolio 16.7.3. SWOT Analysis 16.7.4. Financial Overview 16.7.5. Strategic Overview 16.8. Air Liquide 16.8.1. Company Overview 16.8.2. Product Portfolio 16.8.3. SWOT Analysis 16.8.4. Financial Overview 16.8.5. Strategic Overview 16.9. Vyaire Medical 16.9.1. Company Overview 16.9.2. Product Portfolio 16.9.3. SWOT Analysis 16.9.4. Financial Overview 16.9.5. Strategic Overview 16.10.Invacare Corp. 16.10.1. Company Overview 16.10.2. Product Portfolio 16.10.3. SWOT Analysis 16.10.4. Financial Overview 16.10.5. Strategic Overview 16.11.Chart Industries Inc. 16.11.1. Company Overview 16.11.2. Product Portfolio 16.11.3. SWOT Analysis 16.11.4. Financial Overview 16.11.5. Strategic Overview 17. Pre and Post COVID-19 Impact 17.1. Positive influence on the healthcare industry 17.2. The financial disruption of the manufacturing sector 17.3. Impact of COVID-19 on emerging companies 17.4. Significant mandates in the regulations initiated by healthcare administrations 17.5. The overall economic slowdown of the developing and developed nations 18. FutureWise SME Key Takeaway Points for Client
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders
2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study
3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights
4. Respiratory Care Devices Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances
5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Respiratory Care Devices Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Respiratory Care Devices Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies
7. Respiratory Care Devices Market, By Product Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Therapeutic Devices 7.1.1. PAP Devices 7.1.2. Ventilators 7.1.3. Nebulizers 7.1.4. Humidifiers 7.1.5. Oxygen Concentrators 7.1.6. Inhalers 7.1.7. Reusable Resuscitators 7.1.8. Nitric Oxide Delivery Units 7.1.9. Oxygen Hoods 7.2. Monitoring Devices 7.2.1. Pulse Oximeters 7.2.2. Capnographs 7.2.3. Gas Analyzers 7.3. Diagnostic Devices 7.3.1. Spirometers 7.3.2. Polysomnography Devices 7.3.3. Peak Flow Meters 7.3.4. Other Diagnostic Devices 7.4. Consumables and Accessories 7.4.1. Masks 7.4.2. Reusable Masks 7.4.3. Nasal Masks 7.4.5. Full-face Masks 7.4.6. Nasal pillow masks 7.4.7. Oral Masks 7.4.8. Disposable Mask 7.4.9. Disposable Resuscitators 7.4.10. Tracheostomy Tubes 7.4.11. Nasal Cannulas 7.4.12. Other Consumables and Accessories
8. Respiratory Care Devices Market, By Indication Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Chronic Obstructive Pulmonary Disease (COPD) 8.2. Asthma 8.3. Sleep Apnea 8.4. Infectious Disease 8.5. Other diseases
9. Respiratory Care Devices Market, By End-User Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Hospitals 9.2. Home Care Settings 9.3. Ambulatory Care Centers
10. North America Respiratory Care Devices Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 10.2.1. U.S.A 10.2.2. Canada 10.2.3. Mexico 10.3. Market Size (USD Million) Forecast for North America 2022-2028
11. Latin America Respiratory Care Devices Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. Brazil 11.2.2. Venezuela 11.2.3. Argentina 11.2.4. Rest of Latin America 11.3. Market Size (USD Million) Forecast for Latin America 2022-2028
12. Europe Respiratory Care Devices Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Germany 12.2.2. U.K 12.2.3. France 12.2.4. Italy 12.2.5. Spain 12.2.6. Russia 12.2.7. Poland 12.2.8. Rest of Europe 12.3. Market Size (USD Million) Forecast for Europe 2022-2028
13. Asia Pacific Respiratory Care Devices Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Japan 13.2.2. China 13.2.3. India 13.2.4. Australia and New Zealand 13.2.5. ASEAN 13.2.6. Rest of Asia Pacific 13.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
14. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. GCC 14.2.2. Israel 14.2.3. South Africa 14.2.4. Rest of MEA 14.3. Market Size (USD Million) Forecast for MEA 2022-2028
15. Market Share Analysis and Competitive Landscape 15.1. Global Landscape - Key Players, Revenue and Presence 15.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 15.3. Global Emerging Companies 15.4. North America - Market Share Analysis and Key Regional Players 15.5. Europe - Market Share Analysis and Key Regional Players 15.6. Asia Pacific - Market Share Analysis and Key Regional Players 15.7. Global Key Player - Growth Matrix
16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 16.1. Medtronic 16.1.1. Company Overview 16.1.2. Product Portfolio 16.1.3. SWOT Analysis 16.1.4. Financial Overview 16.1.5. Strategic Overview 16.2. Philips Healthcare 16.2.1. Company Overview 16.2.2. Product Portfolio 16.2.3. SWOT Analysis 16.2.4. Financial Overview 16.2.5. Strategic Overview 16.3. ResMed Inc. 16.3.1. Company Overview 16.3.2. Product Portfolio 16.3.3. SWOT Analysis 16.3.4. Financial Overview 16.3.5. Strategic Overview 16.4. Fisher & Paykel Healthcare Co. Ltd. 16.4.1. Company Overview 16.4.2. Product Portfolio 16.4.3. SWOT Analysis 16.4.4. Financial Overview 16.4.5. Strategic Overview 16.5. Masimo Corp. 16.5.1. Company Overview 16.5.2. Product Portfolio 16.5.3. SWOT Analysis 16.5.4. Financial Overview 16.5.5. Strategic Overview 16.6. Getinge AB 16.6.1. Company Overview 16.6.2. Product Portfolio 16.6.3. SWOT Analysis 16.6.4. Financial Overview 16.6.5. Strategic Overview 16.7. Dragerwerk AG 16.7.1. Company Overview 16.7.2. Product Portfolio 16.7.3. SWOT Analysis 16.7.4. Financial Overview 16.7.5. Strategic Overview 16.8. Air Liquide 16.8.1. Company Overview 16.8.2. Product Portfolio 16.8.3. SWOT Analysis 16.8.4. Financial Overview 16.8.5. Strategic Overview 16.9. Vyaire Medical 16.9.1. Company Overview 16.9.2. Product Portfolio 16.9.3. SWOT Analysis 16.9.4. Financial Overview 16.9.5. Strategic Overview 16.10.Invacare Corp. 16.10.1. Company Overview 16.10.2. Product Portfolio 16.10.3. SWOT Analysis 16.10.4. Financial Overview 16.10.5. Strategic Overview 16.11.Chart Industries Inc. 16.11.1. Company Overview 16.11.2. Product Portfolio 16.11.3. SWOT Analysis 16.11.4. Financial Overview 16.11.5. Strategic Overview
17. Pre and Post COVID-19 Impact 17.1. Positive influence on the healthcare industry 17.2. The financial disruption of the manufacturing sector 17.3. Impact of COVID-19 on emerging companies 17.4. Significant mandates in the regulations initiated by healthcare administrations 17.5. The overall economic slowdown of the developing and developed nations
18. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics